Patent Assignment
Reel/Frame 071905/0166
SECURITY INTEREST
Recorded: 2025-08-01
Received: 2025-08-01
Pages: 7
Assignors
AMNEAL PHARMACEUTICALS LLC
Executed: 2025-08-01
IMPAX LABORATORIES, LLC
Executed: 2025-08-01
Assignee
JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
10 S. DEARBORN ST. L2 FLOOR, CHICAGO, IL, 60603, UNITED STATES
Covered Applications
(21)
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 19/251,149
→
READY-TO-INFUSE OXYTOCIN COMPOSITIONS
App. No. 19/202,110
→
LEVODOPA DOSING REGIMEN
App. No. 19/021,929
→
LEVODOPA DOSING REGIMEN
App. No. 19/022,256
→
LEVODOPA DOSING REGIMEN
App. No. 19/022,531
→
LEVODOPA DOSING REGIMEN
App. No. 19/021,696
→
LEVODOPA DOSING REGIMEN
App. No. 19/022,122
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 19/004,850
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 18/975,144
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 18/911,732
→
LEVODOPA DOSING REGIMEN
App. No. 18/823,575
→
LEVODOPA DOSING REGIMEN
App. No. 18/823,153
→
LEVODOPA DOSING REGIMEN
App. No. 18/817,743
→
LEVODOPA DOSING REGIMEN
App. No. 18/802,458
→
LEVODOPA DOSING REGIMEN
App. No. 18/802,151
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 18/791,632
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 18/789,870
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 18/755,045
→
LEVODOPA DOSING REGIMEN
App. No. 18/634,040
→
BACLOFEN FORMULATIONS AND METHODS OF MINIMIZING PATIENT EXPOSURE TO METABOLITE VARIATIONS
App. No. 18/508,830
→
MULTIFUNCTIONAL RESTRICTIVE VALVE
App. No. 11/788,884
→